Xtant Medical Just Expanded the Trivium Line. The Hardest Conversation Their Reps Will Have Is With Surgeons Who Already Use Trivium.
On 6 May 2026, Xtant Medical commercially launched Trivium Shaped, a new line of pre-shaped bone graft configurations in boats and strips. The product extends the existing Trivium portfolio, which began with the sculptable format launched in April 2025.
Trivium Shaped uses the same PureLoc technology that defines the Trivium line: a proprietary automated DBM milling process that produces elongated, uniform cortical fibres forming the structural foundation of a composite allograft. The composite itself combines elongated demineralised cortical fibres, trabecular cancellous chips, and demineralised bone matrix into a single connected graft matrix. What changes with Trivium Shaped is the form factor. Instead of a sculptable putty, surgeons get pre-shaped, ready-to-use configurations designed to reduce intraoperative preparation time.
For Xtant's sales team, this launch creates a specific and often underestimated training challenge. The hardest sale is not to a new account. It is to a surgeon who already uses the existing product and does not yet see why they need the new one.
The cross-sell problem
When a company launches an entirely new product to a new market, the sales conversation is about awareness and clinical value. The rep introduces a solution the surgeon has not considered. The conversation starts from zero.
Portfolio expansion is different. The surgeon already knows the company. They may already like Trivium Sculptable. They have a workflow that works. The rep's challenge is to introduce a new format without undermining the product the surgeon already trusts, and without sounding like they are simply trying to increase order volume.
The result is a conversation that is psychologically more complex than a cold product introduction. The surgeon's internal logic runs something like this: "I already use your product. It works well. If this new version is better, does that mean the one I've been using was not good enough? And if the current one is fine, why would I change?"
Reps who handle this clumsily either insult the surgeon's current choice or fail to create any reason to consider the new format. Neither outcome is productive.
What the Trivium Shaped conversation actually requires
The clinical case for Trivium Shaped is not that it is better than Trivium Sculptable. It is that it serves different procedural moments better.
A sculptable graft gives the surgeon control: they shape it in the operating room to fit the defect site precisely. That flexibility is valuable in complex or irregular defects. A pre-shaped boat or strip eliminates the shaping step entirely, reducing preparation time and introducing consistency in cases where the geometry is predictable.
The rep's job is to help the surgeon see which cases in their own practice would benefit from each format. The framing matters here: it should never feel like an either-or. It is a portfolio conversation. The best outcome for Xtant is a surgeon who uses Trivium Sculptable for complex cases and Trivium Shaped for straightforward ones, increasing both efficiency and overall graft volume.
Getting there requires the rep to understand the surgeon's case mix well enough to make specific, credible suggestions. "For your standard single-level PLIF cases, the pre-shaped strip could save you two to three minutes of preparation per level" is a conversation. "We have a great new product you should try" is not.
The objections reps will face
Spine surgeons who use Trivium Sculptable and are happy with it will push back in predictable ways.
"I like shaping the graft myself. I get exactly what I need." This is a control objection, and it is legitimate. The rep should not argue against it. Instead, they should acknowledge that sculptable is the right choice when precise shaping matters, then ask about the cases where the surgeon is shaping graft into a standard configuration that matches what Trivium Shaped already provides. If the surgeon is spending time sculpting graft into a shape that comes pre-made, that is the opening.
"How do I know the pre-shaped format performs the same as the sculptable?" This is a reasonable clinical question. The rep needs to explain that Trivium Shaped uses the same PureLoc-processed composite matrix, the same combination of cortical fibres, cancellous chips, and DBM. The biology is identical. What changes is the handling step.
"I don't want to stock another SKU." Inventory is a real concern for surgeons and materials managers. The rep needs to frame Trivium Shaped not as an additional product but as an efficiency tool that may actually simplify preparation and reduce waste in appropriate cases.
"My cases are too variable for pre-shaped grafts." This may be true for some surgeons. The rep needs the confidence to agree when it is, rather than forcing a fit. The strongest cross-sell position is one that respects the surgeon's clinical judgment and only recommends the new format where it genuinely adds value.
Each of these objections requires the rep to listen carefully, respond specifically, and avoid the temptation to oversell. These are skills that develop through practice, not through reading a product brief.
Why portfolio selling is a distinct skill
Selling a new product and cross-selling within a portfolio are different disciplines. A new product sale is about building belief. A cross-sell is about expanding belief without destabilising it.
The cross-selling rep must simultaneously reinforce the value of the existing product, the product the surgeon already chose and trusts, while creating space for the new one. If the rep implies that Trivium Shaped makes Trivium Sculptable obsolete, they risk undermining the surgeon's confidence in a product they are already using. If they are too deferential about the existing product, they fail to create any motivation to consider the new format.
Striking that balance is difficult in theory and even more difficult in a live conversation with a busy surgeon who has three minutes between cases. It requires conversational agility that only comes from having run through the scenario multiple times before the real conversation happens.
How AI roleplay develops the cross-sell skill
An AI roleplay platform can simulate the specific dynamics of a portfolio expansion conversation. The AI surgeon persona starts as a satisfied Trivium Sculptable user, slightly sceptical of the new format and protective of their existing workflow.
When the rep opens the conversation, the AI responds the way a real surgeon would. It asks why the new format is necessary. It pushes back on the efficiency claim. It raises the inventory objection. It tests whether the rep can hold the conversation without disparaging the product the surgeon already uses.
The mistakes reps make in cross-sell conversations are subtle. They do not say the wrong thing in an obvious way. They create a slight impression that the company is pivoting away from the product the surgeon chose. Or they fail to connect the new format to a specific clinical scenario that resonates. These are nuances that only surface in the flow of a realistic conversation, not in a slide deck review.
AI roleplay lets reps make those mistakes in practice, get feedback, and adjust their approach before it matters. A rep who has practised six cross-sell conversations will handle the seventh, the real one, with noticeably more precision.
The distribution channel dimension
Xtant Medical distributes through a nationwide network of independent agents. This adds a layer of complexity to the training challenge. The company does not control the agents' schedules, priorities, or existing product knowledge the way it would with a direct sales force. Getting independent agents confident and capable with a new product format requires a training approach that is flexible, on-demand, and does not require pulling agents away from revenue-generating activity.
AI roleplay fits this model well. An independent agent can practise Trivium Shaped conversations on their own time, between calls, without waiting for a scheduled training session. The platform becomes the always-available practice partner that a distributed sales model needs.
The window matters
Portfolio launches have a narrower commercial window than new product launches. The surgeon is already in the account. The relationship exists. The opportunity to introduce the new format comes during routine interactions that happen on a regular cadence. If the rep is not ready to have the conversation at the next touchpoint, they wait weeks or months for the next natural opening.
For Xtant Medical, the reps and agents who can have a credible Trivium Shaped conversation at their next surgeon interaction will capture early adoption. The ones who need another quarter to feel comfortable with the positioning will lose that window to inertia.
Getting reps ready for a portfolio conversation is not about more content. It is about more practice. And practice, done well, can happen in hours.
TrainBox helps medical device teams practise real surgeon conversations so they're ready when it matters.